Evidence map›Paper›PMID 34665906›Full record

ReviewExperimental dermatology2022

Role of nitric oxide in regulating epidermal permeability barrier function.

Mao-Qiang Man, Joan S Wakefield, Theodora M Mauro, Peter M Elias

Open access · bronzeAbstract readReview
In one paragraph

Review in Experimental dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Valorization of Chum Salmon (Marine drugs · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Bioactive Fractions Isolated fromCurrent drug research reviews · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Evaluation of the in vitro human skin percutaneous absorption of ketoprofen in topical anhydrous and aqueous gels.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Mao-Qiang ManDermatology Service, Veterans Affairs Medical Center San Francisco, and Department of Dermatology, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-0957-4903
Joan S WakefieldDermatology Service, Veterans Affairs Medical Center San Francisco, and Department of Dermatology, University of California San Francisco, San Francisco, California, USA.
Theodora M MauroDermatology Service, Veterans Affairs Medical Center San Francisco, and Department of Dermatology, University of California San Francisco, San Francisco, California, USA.
Peter M EliasDermatology Service, Veterans Affairs Medical Center San Francisco, and Department of Dermatology, University of California San Francisco, San Francisco, California, USA.
San Francisco VA Medical Center · US

Funding

Pathogenesis and Therapy of Ichthyosis in Disorders of Lipid MetabolismR01AR061106 · NIAMS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MAURO, THEODORA M · 2012 to 2022
$3.3M
NIAMS NIH HHS R01 AR061106
6 · The paper itself

Abstract

Nitric oxide (NO), a free radical molecule synthesized by nitric oxide synthases (NOS), regulates multiple cellular functions in a variety of cell types. These NOS, including endothelial NOS (eNOS), inducible NOS (iNOS) and neural NOS (nNOS), are expressed in keratinocytes. Expression levels of both iNOS and nNOS decrease with ageing, and insufficient NO has been linked to the development of a number of disorders such as diabetes and hypertension, and to the severity of atherosclerosis. Conversely, excessive NO levels can induce cellular oxidative stress, but physiological levels of NO are required to maintain the normal functioning of cells, including keratinocytes. NO also regulates cutaneous functions, including epidermal permeability barrier homeostasis and wound healing, through its stimulation of keratinocyte proliferation, differentiation and lipid metabolism. Topical applications of a diverse group of agents which generate nitric oxide (called NO donors) such as S-nitroso-N-acetyl-D,L-penicillamine (SNAP) can delay permeability barrier recovery in barrier-disrupted skin, but iNOS is still required for epidermal permeability barrier homeostasis. This review summarizes the regulatory role that NO plays in epidermal permeability barrier functions and the underlying mechanisms involved.

Indexed as

EpidermisNitric OxideNitric Oxide DonorsNitric Oxide SynthaseNitric Oxide Synthase Type IIPermeabilityNitric OxideNitric Oxide DonorsNitric Oxide SynthaseNitric Oxide Synthase Type IIdifferentiationkeratinocytenitric oxidepermeability barrier

Identifiers

PMID34665906
PMCPMC8897205
OpenAlexW3205442095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.